Trade CLGN stock anytime, 24x5 in Singapore
Regulated by
Monetary Authority of Singapore (MAS)
Trusted by
400,000+ users
CollPlant Biotechnologies Ltd (CLGN) is trading at US$3.85, down 10.47% today as of Sep 22, 16:00 EDT. The company has a market capitalisation of US$5.91M. Over the past 52 weeks, CLGN has traded between US$2.64 and US$31.80. On Syfe you can trade CLGN with $0 commission and add it to your watchlist.
| Previous close | US$4.30 |
|---|---|
| Market cap | US$5.91M |
| 52-week range | US$2.64 – US$31.80 |
| Volume | 110.36K |
| Exchange | US |
Add to Watchlist
Set Price Alert
CollPlant Biotechnologies Ltd
CollPlant Biotechnologies Ltd. operates as a regenerative and aesthetic medicine company. It engages in the research, development, manufacture, and marketing of medical products for tissue repair such as bioprinting of tissues and organs, and medical aesthetics. Its products include VergenixSTR, VergenixFG, and Collink.3D. The company was founded by Oded Shoseyov in June 2004 and is headquartered in Rehovot, Israel.
Year: 2021
CollPlant Biotechnologies Files Prospectus for Resale of 31 Million Shares
Jul 9, 9:29 PM · MT Newswires
CollPlant Biotechnologies Ltd (CLGN) stock is trading at US$3.85, -10.47% from the previous close of US$4.30.
The market cap for CollPlant Biotechnologies Ltd (CLGN) stock is approximately US$5.91M.
The 52-week high for CollPlant Biotechnologies Ltd (CLGN) stock is US$31.80.
The 52-week low for CollPlant Biotechnologies Ltd (CLGN) stock is US$2.64.
CollPlant Biotechnologies Ltd (CLGN) does not currently pay a dividend.
Stay on top of CLGN
Price moves, news and earnings — straight to your inbox.
Est. order value
US$0.00
Snapshot
Popular Stocks in Singapore
